 - Recent evidence also indicates that the effects of chemotherapy may be improved by combining the treatment with monoclonal antibodies, which are purified proteins that are specially made to attach to foreign substances such as cancer cells. A monoclonal antibody called campath alemtuzumab has been manufactured to attach to a protein called CD52 that may target tumor cells or the surrounding inflammatory cells. 